Literature DB >> 8824025

Medical management of gastro-oesophageal reflux disease.

J S Collins1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8824025     DOI： 10.1007/bf02940249

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  12 in total

Review 1.  Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.

Authors:  H R Koelz
Journal:  Scand J Gastroenterol Suppl       Date:  1989

2.  Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.

Authors:  C M Bate; P W Keeling; C O'Morain; S P Wilkinson; D N Foster; R A Mountford; J M Temperley; R F Harvey; D G Thompson; M Davis
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

3.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

Authors:  D J Hetzel; J Dent; W D Reed; F M Narielvala; M Mackinnon; J H McCarthy; B Mitchell; B R Beveridge; B H Laurence; G G Gibson
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

4.  Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial.

Authors:  J G Hatlebakk; A Berstad; L Carling; L E Svedberg; P Unge; P Ekström; L Halvorsen; A Stallemo; N Hovdenak; R Trondstad
Journal:  Scand J Gastroenterol       Date:  1993-03       Impact factor: 2.423

5.  Symptomatic gastroesophageal reflux: incidence and precipitating factors.

Authors:  O T Nebel; M F Fornes; D O Castell
Journal:  Am J Dig Dis       Date:  1976-11

6.  Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.

Authors:  B Hallerbäck; P Unge; L Carling; B Edwin; H Glise; N Havu; E Lyrenäs; K Lundberg
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

7.  Safety experience from long-term treatment with omeprazole.

Authors:  S Joelson; I B Joelson; P Lundborg; A Walan; M A Wallander
Journal:  Digestion       Date:  1992       Impact factor: 3.216

8.  Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.

Authors:  A L Blum; B Adami; M H Bouzo; G Brandstätter; I Fumagalli; J P Galmiche; H Hebbeln; E Hentschel; W Hüttemann; E SChütz
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

Review 9.  Review article: drug therapy for reflux oesophagitis.

Authors:  W A de Boer; G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1994-04       Impact factor: 8.171

10.  Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.

Authors:  C M Bate; S N Booth; J P Crowe; R A Mountford; P W Keeling; B Hepworth-Jones; M D Taylor; P D Richardson
Journal:  Gut       Date:  1995-04       Impact factor: 23.059
View more
  1 in total

Review 1.  Trends in the management of gastro-oesophageal reflux disease.

Authors:  J M Lee; C A O'Morain
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.